These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 8968547

  • 1. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
    Webb TE, Feolde E, Vigne P, Neary JT, Runberg A, Frelin C, Barnard EA.
    Br J Pharmacol; 1996 Dec; 119(7):1385-92. PubMed ID: 8968547
    [Abstract] [Full Text] [Related]

  • 2. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
    Schäfer R, Reiser G.
    Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
    [Abstract] [Full Text] [Related]

  • 3. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
    Simon J, Vigne P, Eklund KM, Michel AD, Carruthers AM, Humphrey PP, Frelin C, Barnard EA.
    Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
    Boyer JL, Zohn IE, Jacobson KA, Harden TK.
    Br J Pharmacol; 1994 Oct; 113(2):614-20. PubMed ID: 7834215
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a P2Y purinoceptor in the brain.
    Simon J, Webb TE, Barnard EA.
    Pharmacol Toxicol; 1995 May; 76(5):302-7. PubMed ID: 7567779
    [Abstract] [Full Text] [Related]

  • 6. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
    Ho C, Hicks J, Salter MW.
    Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
    [Abstract] [Full Text] [Related]

  • 7. Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells.
    Simon J, Filippov AK, Göransson S, Wong YH, Frelin C, Michel AD, Brown DA, Barnard EA.
    J Biol Chem; 2002 Aug 30; 277(35):31390-400. PubMed ID: 12080041
    [Abstract] [Full Text] [Related]

  • 8. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.
    Pintor J, Díaz-Rey MA, Miras-Portugal MT.
    Br J Pharmacol; 1993 Apr 30; 108(4):1094-9. PubMed ID: 8485620
    [Abstract] [Full Text] [Related]

  • 9. Characterization by antagonists of P2-receptors mediating endothelium-dependent relaxation in the rat aorta.
    Hansmann G, Bültmann R, Tuluc F, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov 30; 356(5):641-52. PubMed ID: 9402045
    [Abstract] [Full Text] [Related]

  • 10. Binding of [35S]adenosine 5'-O-(2-thiodiphosphate) to endothelial cells in culture.
    Wilkinson GF, Boarder MR.
    Biochem Pharmacol; 1995 May 17; 49(10):1411-8. PubMed ID: 7763284
    [Abstract] [Full Text] [Related]

  • 11. Characterisation of a recombinant P2Y purinoceptor.
    Simon J, Webb TE, King BF, Burnstock G, Barnard EA.
    Eur J Pharmacol; 1995 Nov 30; 291(3):281-9. PubMed ID: 8719412
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.
    Bültmann R, Dudeck O, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar 30; 353(4):445-51. PubMed ID: 8935712
    [Abstract] [Full Text] [Related]

  • 13. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
    Mateo J, Miras-Portugal MT, Castro E.
    Br J Pharmacol; 1996 Nov 30; 119(6):1223-32. PubMed ID: 8937727
    [Abstract] [Full Text] [Related]

  • 14. Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.
    Najbar AT, Li CG, Rand MJ.
    Br J Pharmacol; 1996 Jun 30; 118(3):537-42. PubMed ID: 8762075
    [Abstract] [Full Text] [Related]

  • 15. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
    Schachter JB, Li Q, Boyer JL, Nicholas RA, Harden TK.
    Br J Pharmacol; 1996 May 30; 118(1):167-73. PubMed ID: 8733591
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of adenylyl cyclase by neuronal P2Y receptors.
    Unterberger U, Moskvina E, Scholze T, Freissmuth M, Boehm S.
    Br J Pharmacol; 2002 Feb 30; 135(3):673-84. PubMed ID: 11834615
    [Abstract] [Full Text] [Related]

  • 17. Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.
    King BF, Dacquet C, Ziganshin AU, Weetman DF, Burnstock G, Vanhoutte PM, Spedding M.
    Br J Pharmacol; 1996 Mar 30; 117(6):1111-8. PubMed ID: 8882604
    [Abstract] [Full Text] [Related]

  • 18. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P, Hechler B, Gachet C, Breittmayer JP, Frelin C.
    Biochem Biophys Res Commun; 1999 Mar 05; 256(1):94-7. PubMed ID: 10066429
    [Abstract] [Full Text] [Related]

  • 19. ATP acting on P2Y receptors triggers calcium mobilization in primary cultures of rat neurohypophysial astrocytes (pituicytes).
    Troadec JD, Thirion S, Petturiti D, Bohn MT, Poujeol P.
    Pflugers Arch; 1999 Apr 05; 437(5):745-53. PubMed ID: 10087153
    [Abstract] [Full Text] [Related]

  • 20. High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.
    Michel AD, Humphrey PP.
    Br J Pharmacol; 1996 Jan 05; 117(1):63-70. PubMed ID: 8825344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.